Posts

Showing posts from June, 2022

Combining genetics and brain MRI can aid in predicting chances of Alzheimer's disease - Science Daily

Image
Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future. In a newly published study, researchers from SFU's Functional and Anatomical Imaging & Shape Analysis Lab (FAISAL) identified distinct properties of brain MRIs and genetics that impact the prediction of Dementia of Alzheimer's Type, or DAT, for patients at various stages of the disease, then developed a biomarker that can help predict future conversion to DAT. "Our findings reveal that while genetic features have lower predictive power than MRI features, combining both modalities can improve the performance in predicting the future conversion to DAT," says study lead author Ghazal Mirabnahrazam, a research assistant currently completing a master's degree in engineering science at SFU. Dementia scores based on genetic data were shown to better predict future DAT progressio

MMR Vaccine (Measles-Mumps-Rubella): What You Should Know - Verywell Health

Image
The introduction and distribution of the MMR ( measles - mumps - rubella ) vaccine in the United States changed the trajectory of these diseases. Illnesses that were commonplace among baby boomers now occur very rarely. Still, vaccination is the best way to protect yourself and the people around you from measles, mumps, and rubella and to maintain the rarity of these diseases in the U.S. This article provides an overview of the MMR vaccine, describes symptoms and complications of measles, mumps, and rubella, and outlines who should and should not get the MMR vaccine. LWA/Dann Tardif / Getty Images What Is the MMR Vaccine? The MMR vaccine protects people from measles, mumps, and rubella. It is a two-dose regimen that is typically recommended to start in early childhood. It is extremely effective at protecting against infection and severe illness. Measles Measles is a highly contagious disease that is characterized by: Rash Fever

Holistic Acne Treatments That Are Better Than What You've Been Doing - The List

Image
Essential oils are commonly used in the treatment of acne, rosacea, eczema, and other skin conditions. A good example is rosemary essential oil, which may help destroy Propionibacterium acnes, the bacterium responsible for acne breakouts, reports a 2007 study published in Planta Medica. You may also try tea tree oil for its antibacterial and anti-inflammatory effects. This natural remedy is rich in terpenes, limonene, and other phytochemicals that may help kill common bacterial strains like P. acnes, S. aureus, Lactobacillus, and E. coli, according to 2015 research featured in the journal Clinical Microbiology Reviews. Another option is lavender essential oil, which can accelerate healing and prevent acne scars. David Karlak and Susan Griffin-Black, two experts interviewed by Byrdie, also recommend cypress, rosehip seed, or jojoba oil. For example, rose oil contains farnesol, a compound that soothes dry skin and reduces excess sebum, notes Griffin-Black. Remember to dilute your f

Mumps Infection With Symptoms of Parotitis, Pancreatitis, and Orchitis Concurrently in an Adolescent Male - Cureus

Image
Mumps is a highly contagious childhood infectious disease caused by the mumps virus. Clinical symptoms of mumps infection among vaccinated young adults are rarely seen. We present an unusual case of a vaccinated young male who presented with a clinical picture suggestive of mumps infection with symptoms of parotitis, pancreatitis, and orchitis. The waning of vaccine-induced immunity and low efficacy of the mumps component of the measles, mumps, and rubella (MMR) vaccine could be the reasons for the same. Our patient was managed with supportive measures for the complications and made an uneventful recovery. It has been postulated that antigenic differences between the vaccine and strain-causing illness may result in a deficient immune response conferred by the vaccine. This case highlights the concerns regarding the effectiveness of the live attenuated vaccine currently in use. Introduction Mumps is an acute systemic viral illness caused by the ribonucleic acid (RNA)

Wellstar and United Healthcare renew relationship in Georgia - CBS 46 News

Image
ATLANTA, Ga. (CBS46) - UnitedHealthcare and Wellstar Health System have reached an agreement on a new, multi-year network relationship. This comes after nine months of failed negotiations and several CBS46 investigations, which highlighted how these contract disputes were putting healthcare for hundreds of thousands of Georgians at risk. One of those Georgians was retired Cobb County teacher, Sandy Arroyo, who lived 15 minutes from Wellstar Kennestone, where he drove fairly regularly because of pre-existing conditions. At the time, he was left with two options: Drive further for in-network care or keep the same doctors, but pay more out-of-pocket. 75-year-old Sandy Arroyo is trying to teach himself the intricacies of healthcare after his insurance company, UnitedHealthcare and his hospital system, Wellstar, cut ties. (CBS46) "What do I do? Where do I go from here? How do I get my bills paid? And still get the healthcare I need?" Arroyo asked CBS46 investigator Rachel Polansky

Innovative Dengue Vaccine Candidate Found Effective and Safe - Vax-Before-Travel

Image
(Vax Before Travel) A second dengue prevention vaccine may soon become available around the world. Japan-based Takeda announced that its dengue vaccine candidate, TAK-003, was recently found very effective in a phase 3 clinical study. TAK-003 prevented 84% of hospitalized dengue cases and 61% of symptomatic dengue cases, with no important safety risks identified, in the overall population, including both seropositive and seronegative individuals through 54 months after vaccination. "The burden of dengue is far-reaching, and over half of the world's population is at risk of dengue each year," said Eng Eong Ooi, Ph.D., M.D., Duke-NUS Medical School, Singapore, in a press release issue don June 9, 2022.  "There is an urgent need for impactful prevention tools to combat the disease." TAK-003 is currently undergoing regulatory review to prevent dengue disease in children and adults in the European Union and select dengue-endemic coun

CDC Recommends COVID-19 Vaccines for Young Children | CDC Online Newsroom | CDC - Centers for Disease Control and Prevention (.gov)

Image
Today, CDC Director Rochelle P.  Walensky , M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices' (ACIP) recommendation that all children 6 months through 5 years of age should receive a COVID-19 vaccine. This expands eligibility for vaccination to nearly 20 million additional children and means that all Americans ages 6 months and older are now eligible for vaccination.   Parents and caregivers can now get their children 6 months through 5 years of age vaccinated with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. All children, including children who have already had COVID-19, should get vaccinated. COVID-19 vaccines have undergone — and will continue to undergo — the most intensive safety monitoring in U.S. history. Parents and caregivers can play an active role in monitoring the safety of these vaccines by signing their children up for v-safe – personalized and confidential health check-ins via text m

Takeda's dengue vaccine candidate delivers continued protection - PharmaTimes

Image
Vital dengue vaccine offers over four years' protection following successful clinical trial Takeda has announced that its dengue vaccine, TAK-003, prevented 84% of hospitalised cases and 61% of symptomatic cases. Furthermore, there were no important safety risks identified among the overall population throughout the four and a half years following vaccination during the phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial. TIDES is a double-blind, randomised, placebo-controlled trial is evaluating the safety and efficacy of two TAK-003 doses. It involves the prevention of laboratory-confirmed symptomatic dengue fever of any severity and due to any of the four dengue virus serotypes in children and adolescents. The new long-term results back-up previously published TIDES data which demonstrated the candidate vaccine met its primary endpoint of overall 80.2% efficacy at the 12-month follow-up, as well as all secondary endpoints for which there were a suffi

Healthcare organizations react to the overturning of Roe V. Wade - WBIR.com

[unable to retrieve full-text content] Healthcare organizations react to the overturning of Roe V. Wade    WBIR.com

Know Your Rights: Reproductive Health Care - HHS.gov

Image
Reproductive health care, including access to birth control and safe and legal abortion care, is an essential part of your health and well-being. While Roe v. Wade was overturned, abortion remains legal in many states, and other reproductive health care services remain protected by law. The U.S. Department of Health and Human Services (HHS) is committed to providing you with accurate and up-to-date information about access to and coverage of reproductive health care and resources. Our goal is to make sure you have appropriate information and support. Your Reproductive Rights: Below you will find information on your right to access care and have it covered by your insurance or other health care coverage if you have it, where to go if you don't have coverage, and how to get information if you don't know. Most health coverage – whether you have public (e.g., Medicaid) or private health coverage (e.g., coverage through the Affordable Care Act Marketplace or through your emp

Environmental influence on transmission, 28 April 2020 (updated 2 May 2020) - GOV.UK

Image
SAGE – Environmental and Modelling Group Executive summary 1. We consider transmission through airborne, droplet and contact routes and consider the evidence relating to time spent in an environment, distance to the source (2 metres rule), transmission on surfaces and ventilation as a mitigating factor. This paper is based on evidence available as at 26 April 2020. 2. Transmission depends on both the amount of virus present and the duration and method of exposure, and hence it is important that both factors are considered when evaluating risk. 3. The risk of short range transmission through aerosol and droplets decreases with distance and there is evidence that 2 metres is a distance where risk drops to an acceptable level for face-to-face interactions. 4. The risk of short range transmission through aerosol and droplets also increases with time. For example a 6 second exposure at 1 metre is comparable to a 1 minute exposure at 2 metres. Longer duration exposures i